These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20820596)

  • 1. De novo structure-based design of anion receptors.
    Hay BP
    Chem Soc Rev; 2010 Oct; 39(10):3700-8. PubMed ID: 20820596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-based de novo design of drug-like molecules.
    Schneider G; Fechner U
    Nat Rev Drug Discov; 2005 Aug; 4(8):649-63. PubMed ID: 16056391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo structure-based design of bisurea hosts for tetrahedral oxoanion guests.
    Bryantsev VS; Hay BP
    J Am Chem Soc; 2006 Feb; 128(6):2035-42. PubMed ID: 16464105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Search for improved host architectures: application of de novo structure-based design and high-throughput screening methods to identify optimal building blocks for multidentate ethers.
    Hay BP; Oliferenko AA; Uddin J; Zhang C; Firman TK
    J Am Chem Soc; 2005 Dec; 127(48):17043-53. PubMed ID: 16316251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quest for novel chemical matter and the contribution of computer-aided de novo design.
    Pirard B
    Expert Opin Drug Discov; 2011 Mar; 6(3):225-31. PubMed ID: 22647201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo drug design: integration of structure-based and ligand-based methods.
    Dean PM; Lloyd DG; Todorov NP
    Curr Opin Drug Discov Devel; 2004 May; 7(3):347-53. PubMed ID: 15216939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer design of bioactive molecules: a method for receptor-based de novo ligand design.
    Moon JB; Howe WJ
    Proteins; 1991; 11(4):314-28. PubMed ID: 1758885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.
    Firth-Clark S; Willems HM; Williams A; Harris W
    J Chem Inf Model; 2006; 46(2):642-7. PubMed ID: 16562994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural criteria for the rational design of selective ligands: convergent hydrogen bonding sites for the nitrate anion.
    Hay BP; Gutowski M; Dixon DA; Garza J; Vargas R; Moyer BA
    J Am Chem Soc; 2004 Jun; 126(25):7925-34. PubMed ID: 15212541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in de novo design strategy for practical lead identification.
    Honma T
    Med Res Rev; 2003 Sep; 23(5):606-32. PubMed ID: 12789688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable metal-organic complexes as anion hosts.
    Pérez J; Riera L
    Chem Soc Rev; 2008 Dec; 37(12):2658-67. PubMed ID: 19020679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flux (1): a virtual synthesis scheme for fragment-based de novo design.
    Fechner U; Schneider G
    J Chem Inf Model; 2006; 46(2):699-707. PubMed ID: 16563000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and challenges in high-resolution refinement of protein structure models.
    Misura KM; Baker D
    Proteins; 2005 Apr; 59(1):15-29. PubMed ID: 15690346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural design criteria for anion hosts: strategies for achieving anion shape recognition through the complementary placement of urea donor groups.
    Hay BP; Firman TK; Moyer BA
    J Am Chem Soc; 2005 Feb; 127(6):1810-9. PubMed ID: 15701016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
    Hartenfeller M; Proschak E; Schüller A; Schneider G
    Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo design and characterization of a helical hairpin eicosapeptide; emergence of an anion receptor in the linker region.
    Rudresh ; Ramakumar S; Ramagopal UA; Inai Y; Goel S; Sahal D; Chauhan VS
    Structure; 2004 Mar; 12(3):389-96. PubMed ID: 15016355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.